Here are 10 recent partnerships and acquisitions for orthopedic and spine device companies.
Alphatec Spine closed its acquisition of certain assets of Phygen, which will likely strengthen the company's capabilities.
DSM has partnered with AxioMed Spine to extend an existing licensing and supply agreement for CarboSil Thermoplastic Silicon-Polycarbonate-urethane material for use with AxioMed's Freedom Lumbar and Freedom Cervical Discs.
Medtronic has completed its $755 million acquisition of Chinese orthopedic device company China Kanghui Holdings to strengthen its product portfolio and add new products in trauma, spine and joint reconstruction.
Paradigm Spine and OM HealthCare Logistics signed a multi-year supply chain services agreement for the domestic healthcare marketplace to distribute the recently FDA-approved coflex device.
Smith & Nephew has purchased Texas-based Healthpoint Biotherapeutics for $782 million with the hopes that the acquisition will strengthen its position in the bioactive wound care market.
Spine Wave has completed a definitive agreement to acquire Santa Clara Technology, which develops technology for expandable titanium interbody cage platforms.
Symmetry Medical is partnering with MTG Medical Technologies for exclusive distribution in Europe of Symmetry Surigcal's portfolio.
Symmetry Surgical is partnering with Italian device maker Biocommercial to distribute its portfolio of surgical instruments across Europe and expand the company's global reach.
TranS1 has reached a distribution agreement with Beijing Jiade Sunshine that covers the sale of AxiaLIF products, which were granted a registration certificate by China's State Food and Drug Administration, in most of China.
Wright Medical Group announced it will purchase regenerative medicine company BioMimetic Therapeutics for up to $380 million, pending FDA approval of a new BioMimetic product.
More Articles on Orthopedic Devices:
Bringing Two-Level Artificial Cervical Disc Replacements to the US Market: Q&A With Joe Ross of LDR
Zimmer Sues Supplier for Relocating Production
Medical Device Industry: 3 Ongoing Challenges
Alphatec Spine closed its acquisition of certain assets of Phygen, which will likely strengthen the company's capabilities.
DSM has partnered with AxioMed Spine to extend an existing licensing and supply agreement for CarboSil Thermoplastic Silicon-Polycarbonate-urethane material for use with AxioMed's Freedom Lumbar and Freedom Cervical Discs.
Medtronic has completed its $755 million acquisition of Chinese orthopedic device company China Kanghui Holdings to strengthen its product portfolio and add new products in trauma, spine and joint reconstruction.
Paradigm Spine and OM HealthCare Logistics signed a multi-year supply chain services agreement for the domestic healthcare marketplace to distribute the recently FDA-approved coflex device.
Smith & Nephew has purchased Texas-based Healthpoint Biotherapeutics for $782 million with the hopes that the acquisition will strengthen its position in the bioactive wound care market.
Spine Wave has completed a definitive agreement to acquire Santa Clara Technology, which develops technology for expandable titanium interbody cage platforms.
Symmetry Medical is partnering with MTG Medical Technologies for exclusive distribution in Europe of Symmetry Surigcal's portfolio.
Symmetry Surgical is partnering with Italian device maker Biocommercial to distribute its portfolio of surgical instruments across Europe and expand the company's global reach.
TranS1 has reached a distribution agreement with Beijing Jiade Sunshine that covers the sale of AxiaLIF products, which were granted a registration certificate by China's State Food and Drug Administration, in most of China.
Wright Medical Group announced it will purchase regenerative medicine company BioMimetic Therapeutics for up to $380 million, pending FDA approval of a new BioMimetic product.
More Articles on Orthopedic Devices:
Bringing Two-Level Artificial Cervical Disc Replacements to the US Market: Q&A With Joe Ross of LDR
Zimmer Sues Supplier for Relocating Production
Medical Device Industry: 3 Ongoing Challenges